Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut (NCT07157189) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut
30 participantsStarted 2026-09-30
Plain-language summary
A cross-sectional, observational study surveying the clinical, laboratory, and therapeutic characteristics of Behçet's disease patients in a tertiary care center in Upper Egypt
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who fulfil the international study group criteria (ISG) which require the presence of recurrent oral ulceration plus at least two of the following: recurrent genital ulcers, eye lesions (uveitis or retinal vasculitis), skin lesions, or a positive pathergy test (12). and the revised International Criteria of BD (rICBD)
Exclusion Criteria:
* Patients with unconfirmed diagnosis of BD.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is described as an observational study measuring how common certain symptoms are in Behçet's disease patients — does that mean it's collecting data rather than testing a new treatment, and would joining it actually change anything about my care?
2Since this study is based in Assiut and hasn't started recruiting yet, can you tell me whether it would realistically be accessible to me, and whether waiting for it to open makes sense given where my disease stands right now?
3The trial is focused on analyzing clinical and laboratory features of Behçet's disease — what kinds of tests, exams, or data collection would I likely be asked to participate in, and how much of a time commitment would that involve?
4Because this isn't a treatment trial, should I be looking at separate studies or standard therapies in parallel rather than viewing participation here as a treatment option?
5Given that Behçet's disease can vary a lot from person to person, would my specific symptoms and disease pattern make me a good candidate to contribute meaningful data to a study like this one?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Proportion of key clinical manifestations in Behçet's disease patients